Semen Test for Prostate Cancer May Improve Diagnosis, Study Says
This article is for subscribers only.
Semen contains prostate cancer biomarkers that could over time improve diagnosis of the condition, a group of Australian researchers said.
After analyzing seminal fluid samples from 60 men, the researchers discovered tiny molecules called microRNAs known to be elevated in prostate cancer. Some of the molecules were “surprisingly accurate” in detecting the cancer and its severity, according to a study published in the journal Endocrine-Related Cancer.